G. Villares

发表

PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.

M. Bar‐eli, M. Zigler, T. Kamiya, 2011, Cancer research.

Correction: Corrigendum: Src activation by β-adrenoreceptors is a key switch for tumour metastasis

Theodoros G. Soldatos, Liz Y. Han, A. Zien, 2013, Nature Communications.

CREB Inhibits AP-2α Expression to Regulate the Malignant Phenotype of Melanoma

M. Bar‐eli, Li Huang, M. Zigler, 2010, PloS one.

Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.

M. Bar‐eli, M. Zigler, A. Dobroff, 2011, Seminars in cancer biology.

Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.

M. Bar‐eli, Li Huang, M. Zigler, 2009, Cancer research.

Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis*

M. Hung, M. Bar‐eli, V. Prieto, 2009, The Journal of Biological Chemistry.

Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection

M. Bar‐eli, G. Villares, Rebecca A. Rosero, 2016, Front. Genet..

Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.

M. Bar‐eli, R. Alani, Li Huang, 2011, Cancer research.

Microenvironment and Immunology Expression of Id-1 Is Regulated byMCAM / MUC 18 : AMissing Link in Melanoma Progression

M. Bar‐eli, R. Alani, Li Huang, 2011 .

Carbon nanotube capsules enhance the in vivo efficacy of cisplatin.

S. Hilsenbeck, L. Wilson, M. Lewis, 2017, Acta biomaterialia.

Tumor Immunotherapy in Melanoma

D. Lev, M. Bar‐eli, M. Zigler, 2008, American journal of clinical dermatology.

Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype

M. Bar‐eli, Li Huang, M. Zigler, 2010, Proceedings of the National Academy of Sciences.

Targeting EGFR in bladder cancer.

D. McConkey, M. Bar‐eli, M. Zigler, 2007, World journal of urology.

NFAT1 Directly Regulates IL8 and MMP3 to Promote Melanoma Tumor Growth and Metastasis.

C. Ivan, M. Bar‐eli, V. Prieto, 2016, Cancer research.

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.

Liz Y. Han, A. Sood, C. Landen, 2008, Journal of the National Cancer Institute.

Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma*

M. Bar‐eli, Li Huang, M. Zigler, 2009, The Journal of Biological Chemistry.

Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.

Prahlad T. Ram, K. Baggerly, P. Ram, 2011, Journal of the National Cancer Institute.

Silencing of p 130 Cas in Ovarian Carcinoma : A Novel Mechanism for Tumor Cell Death

Prahlad T. Ram, K. Baggerly, P. Ram, 2011 .

Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.

A. Sood, M. Bar‐eli, Hong Wu, 2008, Cancer research.

Src activation by β-adrenoreceptors is a key switch for tumor metastasis

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2012, Nature Communications.

Src activation by b-adrenoreceptors is a key switch for tumour metastasis

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2013 .

The Emerging Role of the Thrombin Receptor (PAR-1) in Melanoma Metastasis - a Possible Therapeutic Target

M. Bar‐eli, M. Zigler, G. Villares, 2011, Oncotarget.

RETRACTED ARTICLE: Targeting EGFR in bladder cancer

D. McConkey, M. Bar‐eli, M. Zigler, 2007, World journal of urology.

Emerging Roles of PAR-1 and PAFR in Melanoma Metastasis

M. Bar‐eli, V. Melnikova, G. Villares, 2008, Cancer Microenvironment.

Mutations Within the Kinase Domain and Truncations of the Epidermal Growth Factor Receptor Are Rare Events in Bladder Cancer: Implications for Therapy

K. Aldape, O. Bogler, H. Grossman, 2006, Clinical Cancer Research.

Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors.

I. Fidler, R. Kerbel, Toru Nakamura, 2008, Neoplasia.

Regulation of Melanoma Progression by the Tumor Microenvironment: The Roles of PAR-1 and PAFR

M. Bar‐eli, G. Villares, 2008 .

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.

Liz Y. Han, A. Sood, C. Landen, 2008, Journal of the National Cancer Institute.

Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis*

M. Hung, M. Bar‐eli, V. Prieto, 2009, The Journal of Biological Chemistry.

PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.

M. Bar‐eli, M. Zigler, T. Kamiya, 2011, Cancer research.

Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.

M. Bar‐eli, M. Zigler, A. Dobroff, 2011, Seminars in cancer biology.

Silencing cAMP-response Element-binding Protein (CREB) Identifies CYR61 as a Tumor Suppressor Gene in Melanoma*

M. Bar‐eli, Li Huang, M. Zigler, 2009, The Journal of Biological Chemistry.

Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.

Liz Y. Han, C. Landen, R. Langley, 2008, Journal of the National Cancer Institute.